- ►annals.org [PDF] G Parmigiani, S Chen, ES Iversen Jr, TM … - Annals of internal medicine, 2007 - Am Coll Physicians Giovanni Parmigiani, PhD; Sining Chen, PhD; Edwin S. Iversen Jr., PhD; Tara M.
Friebel, MPH; Dianne M. Finkelstein, PhD; Hoda Anton-Culver, PhD; Argyrios
Ziogas, PhD; Barbara L. Weber, MD; Andrea Eisen, MD; Kathleen E. Malone, ... Cited by 26 - Related articles - BL Direct - All 8 versions
- ►jcojournal.org KJ Vogel, DP Atchley, J Erlichman, KR … - Journal of Clinical Oncology, 2007 - jcojournal.org Purpose The BRCAPRO model, used to predict a family's likelihood of carrying a
BRCA1 or BRCA2 mutation, was designed using mutation frequencies of white and
Ashkenazi Jewish populations, and may not be applicable to other ... Cited by 13 - Related articles - All 4 versions
- ►ascopubs.org CH Barcenas, GM Hosain, B Arun, J Zong, X … - Journal of Clinical Oncology, 2006 - jco.ascopubs.org Purpose Carrier prediction models estimate the probability that a person has a
BRCA mutation. We evaluated the accuracy of the BOADICEA model and compared its
performance with that of other models (BRCAPRO, Myriad I and II, Couch, and ... Cited by 47 - Related articles - All 9 versions
NY Rao, Z Hu, WF Li, J Huang, ZL Ma, B … - Breast Cancer Research and Treatment, 2009 - Springer Models for predicting BRCA1 and BRCA2 mutations in Han ... Chinese familial
breast and/or ovarian cancer patients ... Nan-Yan Rao Æ Zhen Hu Æ Wen-Feng Li
Æ Juan Huang Æ Zhong-Liang Ma Æ Bin Zhang Æ Feng-Xi Su Æ Jie Zhou Æ ... Cited by 5 - Related articles - All 2 versions
EM John, A Miron, G Gong, AI Phipps, A … - Jama, 2007 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Information on ... Cited by 38 - Related articles - BL Direct - All 3 versions
- ►ascopubs.org PA James, R Doherty, M Harris, BN Mukesh, A … - Journal of Clinical Oncology, 2006 - jco.ascopubs.org PATIENTS AND METHODS: Two hundred fifty-seven families who had completed BRCA1
and BRCA2 mutation screening were assessed by six models representing the major
methodologies used to assess the likelihood of a pathogenic mutation. The ... Cited by 52 - Related articles - All 10 versions
[CITATION] Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2
C Capalbo, E Ricevuto, A Vestri, T Sidoni, A … - European Journal of Human Genetics, 2005 - nature.com Inherited mutations of the BRCA1/2 genes confer a significantly increased risk
for breast and/or ovarian cancer development. Several models were elaborated to
help genetic counsellors in selecting individuals with high probability of ... Cited by 11 - Related articles - BL Direct - All 3 versions
[CITATION] PROSE Study Group. Bilateral prophylactic mastectomy reduces breast cancer risk in …
C Apicella, L Andrews, SV Hodgson, SA … - Breast Cancer Res, 2003 - biomedcentral.com Introduction On average, about 1 in 40 people of Ashkenazi Jewish descent carry
a copy of one of the ancestral mutations 185delAG and 5382insC in BRCA1 and
6174delT in BRCA2 [1]. Female carriers have a high lifetime risk of Cited by 23 - Related articles - View as HTML - All 10 versions
